Evidence map›Paper›PMID 37243254›Full record

ArticleViruses2023

The Dimeric Peptide (KKYRYHLKPF)

Gabriela Miranda Ayusso, Maria Letícia Duarte Lima, Paulo Ricardo da Silva Sanches, Igor Andrade Santos, Daniel Oliveira Silva Martins, Pâmela Jóyce Previdelli da Conceição, Tamara Carvalho, Vivaldo Gomes da Costa, Cíntia Bittar, Andres Merits and 5 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

Gabriela Miranda AyussoInstitute of Biosciences, Letters and Exact Sciences, São Paulo State University, São José do Rio Preto 15054-000, SP, Brazil.ORCID 0000-0002-6008-634X
Maria Letícia Duarte LimaInstitute of Biosciences, Letters and Exact Sciences, São Paulo State University, São José do Rio Preto 15054-000, SP, Brazil.ORCID 0000-0002-3269-0662
Paulo Ricardo da Silva SanchesSchool of Pharmaceutical Sciences, São Paulo State University, Araraquara 14800-903, SP, Brazil.
Igor Andrade SantosInstitute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia 38408-100, MG, Brazil.ORCID 0000-0001-7750-4045
Daniel Oliveira Silva MartinsInstitute of Biosciences, Letters and Exact Sciences, São Paulo State University, São José do Rio Preto 15054-000, SP, Brazil.ORCID 0000-0002-8722-2663
Pâmela Jóyce Previdelli da ConceiçãoInstitute of Biosciences, Letters and Exact Sciences, São Paulo State University, São José do Rio Preto 15054-000, SP, Brazil.
Tamara CarvalhoInstitute of Biosciences, Letters and Exact Sciences, São Paulo State University, São José do Rio Preto 15054-000, SP, Brazil.
Vivaldo Gomes da CostaInstitute of Biosciences, Letters and Exact Sciences, São Paulo State University, São José do Rio Preto 15054-000, SP, Brazil.
Cíntia BittarInstitute of Biosciences, Letters and Exact Sciences, São Paulo State University, São José do Rio Preto 15054-000, SP, Brazil.
Andres MeritsInstitute of Technology, University of Tartu, 50090 Tartu, Estonia.ORCID 0000-0001-8193-0071
Norival Alves Santos-FilhoInstitute of Chemistry, São Paulo State University, Araraquara 14800-060, SP, Brazil.ORCID 0000-0002-0344-6900
Eduardo Maffud CilliInstitute of Chemistry, São Paulo State University, Araraquara 14800-060, SP, Brazil.ORCID 0000-0002-4767-0904
Ana Carolina Gomes JardimInstitute of Biosciences, Letters and Exact Sciences, São Paulo State University, São José do Rio Preto 15054-000, SP, Brazil.ORCID 0000-0002-6348-7923
Marilia de Freitas CalmonInstitute of Biosciences, Letters and Exact Sciences, São Paulo State University, São José do Rio Preto 15054-000, SP, Brazil.
Paula RahalInstitute of Biosciences, Letters and Exact Sciences, São Paulo State University, São José do Rio Preto 15054-000, SP, Brazil.ORCID 0000-0001-5693-6148
Universidade Estadual Paulista (Unesp) · BRUniversidade Federal de Uberlândia · BRRockefeller University · USUniversity of Tartu · EE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chikungunya virus (CHIKV) and Zika virus (ZIKV) are important disease-causing agents worldwide. Currently, there are no antiviral drugs or vaccines approved to treat these viruses. However, peptides have shown great potential for new drug development. A recent study described (p-BthTX-I)

Indexed as

Chikungunya FeverChikungunya virusCOVID-19VirusesZika VirusZika Virus InfectionAnimalsAntiviral AgentsChlorocebus aethiopsHumansPeptidesSARS-CoV-2Vero CellsVirus ReplicationAntiviral AgentsPeptidesantiviralCHIKVpeptideZIKV

Identifiers

PMID37243254
PMCPMC10222827
OpenAlexW4376612334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.